Market Place
Sourcing Support
Pfizer Addresses Proposal For Metsera
31 Oct 2025 //
BUSINESSWIRE
Viiv Healthcare Initiates `Risk To Reasons` Program for Women
28 Oct 2025 //
PHARMIWEB
Pfizer Whistleblower Becky McClain Releases Memoir ‘Exposed’
28 Oct 2025 //
PR NEWSWIRE
Pfizer`s Braftovi+Mektovi Demonstrates Prolonged Survival
22 Oct 2025 //
INDPHARMAPOST
Flagship Pioneering Expands Small Molecule Medicines & Design
22 Oct 2025 //
PR NEWSWIRE
Enzalutamide Leads To 40% Lower Risk Of Death In Prostate Cancer
22 Oct 2025 //
INDPHARMAPOST
COVID-19 Vaccines May Help Some Cancer Patients Fight Tumors
22 Oct 2025 //
ECONOMICTIMES
Flagship Brings AI Drug Discovery Firm Expedition Out Of Stealth
22 Oct 2025 //
FIERCE BIOTECH
GSK And Viiv Healthcare Pledge £6M To Boost Community Health
21 Oct 2025 //
PHARMIWEB
Companies Tackle Swift Production Of Custom mRNA Therapies Fast
21 Oct 2025 //
BIOSPACE
Vepdegestrant VERITAC-2 Data Support Benefit In ESR1+ Cancer
20 Oct 2025 //
GLOBENEWSWIRE
IDEAYA Ph2 Combo Shows OS Benefit in Uveal Melanoma at SMR 2025
20 Oct 2025 //
PR NEWSWIRE
Fda`s Lost Leaders: Where Are They Now?
20 Oct 2025 //
BIOSPACE
Astellas-Pfizer`s Combo Halves Risk of Death in Bladder Cancer
20 Oct 2025 //
FIERCE PHARMA
Pfizer`s Braftovi + Mektovi Sustain Long-Term Survival in Cancer
19 Oct 2025 //
PHARMIWEB
Novartis` Pluvicto Slows Progression In Earlier Prostate Cancer
19 Oct 2025 //
FIERCE PHARMA
Keytruda, Padcev Cut Risk Of Death By 50% In MIBC Patient Subset
18 Oct 2025 //
FIERCE PHARMA
ViiV’s Dovato Matches Biktarvy Efficacy With Less Weight Gain
17 Oct 2025 //
BUSINESSWIRE
Pfizer’s Tukysa Improves PFS in HER2+ Breast Cancer
17 Oct 2025 //
INDPHARMAPOST
ESMO: Pfizer Sees Year-Long Weight Gain In Cancer Patients
17 Oct 2025 //
FIERCE BIOTECH
Az`s Imfinzi Looks Set Up For Another Bladder Cancer Expansion
17 Oct 2025 //
FIERCE PHARMA
Pfizer Scores Again In Her2-Positive Breast Cancer
14 Oct 2025 //
FIERCE PHARMA
Pfizer CEO Urges US Pharma Industry To Collaborate With China
14 Oct 2025 //
REUTERS
Pfizer Showcases Respiratory Health, Infectious Disease Research
13 Oct 2025 //
BUSINESSWIRE
Arvinas Showcases Vepdegestrant Data At 2025 ESMO Congress
13 Oct 2025 //
GLOBENEWSWIRE
Astrazeneca Strikes DTC Deal With Trump Administration
10 Oct 2025 //
BIOSPACE
Astrazeneca To Formalize MFN Agreement With Trump: MSNBC
10 Oct 2025 //
FIERCE PHARMA
Pfizer Declares Fourth-Quarter 2025 Dividend
09 Oct 2025 //
BUSINESSWIRE
Pfizer Beat Out Two Other Metsera Suitors For Takeover
07 Oct 2025 //
BIOSPACE
C4 Therapeutics, Pfizer Partner On Cemsidomide And Elranatamab
01 Oct 2025 //
GLOBENEWSWIRE
Pfizer To Offer Drugs at Discount in Agreement with US Government
01 Oct 2025 //
BIOSPACE
Pfizer`s New Prize Metsera Touts 14% Weight Loss For Glp-1
30 Sep 2025 //
FIERCE BIOTECH
Pfizer Highlights Redefining Standards of Care in Cancer at ESMO
25 Sep 2025 //
BUSINESSWIRE
Pfizer to Acquire Metsera and its Next-Gen Obesity Portfolio
24 Sep 2025 //
PRESS RELEASE
Arvinas Cuts 15% After Dropping Pfizer-Partnered Asset
19 Sep 2025 //
BIOSPACE
Pfizer, Arvinas Lose Interest in Commercializing PROTAC Drug
18 Sep 2025 //
FIERCE BIOTECH
6 Pharma Layoffs Could Eliminate Over 39,000 Jobs
18 Sep 2025 //
BIOSPACE
Arvinas Enhances Pfizer Collaboration, Takes Steps to Boost
17 Sep 2025 //
GLOBENEWSWIRE
NastLaw Announces Settlement in Generic Pharma Pricing Litigation
11 Sep 2025 //
PR NEWSWIRE
Vyome Holdings Bolsters Team for Pivotal Trial Studies
09 Sep 2025 //
PHARMAWEB
Pfizer Vet Becomes CEO at Phase 3-Ready Biotech
09 Sep 2025 //
FIERCE BIOTECH
Pfizer, BioNTech Report LP.8.1 COVID-19 Vaccine Immune Response
08 Sep 2025 //
PHARMAWEB
DPIIT Inks MoU with Pfizer to Boost India`s Healthcare Innovation
05 Sep 2025 //
INDPHARMAPOST
Pfizer CEO Responds to Trump’s COVID Touting Vaccine Success
05 Sep 2025 //
BIOSPACE
Prasad Signals Steeper Requirements for COVID-19 Vaccines
03 Sep 2025 //
BIOSPACE
Pfizer, Valneva boosted by updated Lyme vaccine data
03 Sep 2025 //
FIERCE BIOTECH
Lilly Halts Two Mid-Stage Trials for Obesity Asset
02 Sep 2025 //
BIOSPACE
Olema Oncology, Pfizer Partner to Combine Palazestrant
02 Sep 2025 //
GLOBENEWSWIRE
Pfizer to discontinue low-dose ATTR drug Vyndaqel in US in 2025
29 Aug 2025 //
FIERCE PHARMA
Pfizer, Moderna score updated COVID Vaccine Approvals From FDA
29 Aug 2025 //
FIERCE PHARMA
Enforcement Report - Week of August 27, 2025
27 Aug 2025 //
FDA
Pfizer Reduces 100 Jobs at Former Seagen HQ in Digital
27 Aug 2025 //
BIOSPACE
Pfizer lays off 100 workers at former Seagen HQ
26 Aug 2025 //
FIERCE PHARMA
Enanta Files Patent Suit Against Pfizer in Europe
21 Aug 2025 //
ENDPOINTS
Enforcement Report - Week of August 20, 2025
20 Aug 2025 //
FDA
Pfizer`s Sickle-Cell Treatment Effort Falter as Drug Fails Study
18 Aug 2025 //
REUTERS
AZ, Genentech, Merck top oncology HCP promotions: report
14 Aug 2025 //
FIERCE PHARMA
Padcev-Keytruda Combo Delivers Bladder Cancer `breakthrough`
13 Aug 2025 //
PRESS RELEASE
Pfizer Debuts 20-Valent Pneumococcal Vaccine for Adults in India
12 Aug 2025 //
INDPHARMAPOST
FDA May Reject Renewal of Pfizer`s Kid COVID Shot Authorization
12 Aug 2025 //
FIERCE PHARMA
